Valuation: Olympus Corporation

Market Cap 1,882B 11.58B 10.15B 9.38B 8.63B 16.27B 1,116B 16.53B 112B 43.96B 546B 43.46B 42.52B P/E 2027 *
19.5x
P/E 2028 * 16.2x
Enterprise Value 1,952B 12.01B 10.53B 9.73B 8.95B 16.88B 1,158B 17.15B 116B 45.6B 567B 45.09B 44.11B EV / Sales 2027 *
1.83x
EV / Sales 2028 * 1.75x
Free-Float
94.53%
Yield 2027 *
1.74%
Yield 2028 * 1.82%
1 week-1.25%
Current month+4.27%
1 month+6.56%
3 months+13.16%
6 months-5.72%
Current year-10.73%
1 week 1,735.5
Extreme 1735.5
1,790
1 month 1,621
Extreme 1621
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.25%+5.76%-20.56% 11.59B
-1.17%-0.43%+26.88%-2.24% 198B
-1.33%+0.47%+5.82%-17.71% 144B
+2.24%-13.25%-31.90%+1.58% 122B
-0.59%-1.97%-57.77%-18.13% 65.44B
-0.85%-7.40%+11.13%-8.26% 49.36B
+0.65%-0.59%-23.34%-31.15% 44.74B
-0.91%-2.82%+14.27%+4.58% 37.13B
-3.10%-4.20%+24.35%+27.80% 36.23B
-0.19%+0.06%-23.00%-9.43% 28.7B
Average -0.88%-2.79%-4.78%-7.35% 73.77B
Weighted average by Cap. -1.07%-2.85%-1.63%-6.94%

Financials

2027 *2028 *
Net sales 1,067B 6.56B 5.75B 5.32B 4.89B 9.23B 633B 9.37B 63.57B 24.92B 310B 24.64B 24.1B 1,108B 6.82B 5.97B 5.52B 5.08B 9.58B 657B 9.74B 66.03B 25.88B 322B 25.59B 25.04B
Net income 98.73B 607M 532M 492M 453M 854M 58.57B 868M 5.88B 2.31B 28.66B 2.28B 2.23B 118B 724M 635M 587M 540M 1.02B 69.83B 1.03B 7.02B 2.75B 34.17B 2.72B 2.66B
Net Debt 70.42B 433M 380M 351M 323M 609M 41.77B 619M 4.2B 1.65B 20.44B 1.63B 1.59B 52.07B 320M 281M 260M 239M 450M 30.89B 458M 3.1B 1.22B 15.11B 1.2B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-20 ¥1,771.50 0.00% 1,534,600
26-07-17 ¥1,771.50 +1.40% 6,334,600
26-07-16 ¥1,747.00 0.00% 3,845,700
26-07-15 ¥1,747.00 -2.62% 3,274,100
26-07-14 ¥1,794.00 +1.04% 3,904,800
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,771.50JPY
Average target price
1,913.08JPY
Spread / Average Target
+7.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock